Institution statistics

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. - United Kingdom 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:600-700
Networking Rank (Reputation):300-400
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:900-1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:900-1000
Total Project Funding:800-900
Total Project Funding per Partner:600-700
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:600-700
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 42
As coordinator: 0
As participant: 41
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 109.062.996 303.173 9
2018 0 78.314.174 0 5
2017 0 29.375.516 323.750 5
2016 0 100.045.313 77.281 4
2015 0 24.408.946 773.288 3
2012 0 3.935.114 280.861 1
2011 0 11.982.403 9.000 1
2010 0 2.912.936 659.502 1
2009 0 5.057.750 389.058 1
2008 0 15.236.528 1.356.884 4
2007 0 2.850.851 285.085 1
2006 0 2.347.496 167.678 1
2005 162.448 22.498.527 948.127 1 2
2004 0 18.490.000 834.211 2
2002 0 997.545 199.509 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA14
JANSSEN PHARMACEUTICA NV12
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE10
BAYER AKTIENGESELLSCHAFT9
ELI LILLY AND COMPANY LIMITED9
UCB BIOPHARMA SPRL9
KATHOLIEKE UNIVERSITEIT LEUVEN8
PFIZER LIMITED8
ASTRAZENECA AB7
F HOFFMANNLA ROCHE7
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER7
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
NOVO NORDISK6
THE UNIVERSITY OF MANCHESTER6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
KAROLINSKA INSTITUTET5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN5
SANOFIAVENTIS DEUTSCHLAND5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5
UNIVERSITE DE GENEVE5
UNIVERSITY COLLEGE LONDON5
ACADEMISCH ZIEKENHUIS GRONINGEN4
BOEHRINGER INGELHEIM INTERNATIONALGMBH4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE4
CONSIGLIO NAZIONALE DELLE RICERCHE4
KING'S COLLEGE LONDON4
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON4
STICHTING KATHOLIEKE UNIVERSITEIT4
TECHNISCHE UNIVERSITAET DRESDEN4
THE UNIVERSITY OF LIVERPOOL4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT4
UNIVERSITE LIBRE DE BRUXELLES4
UNIVERSITEIT MAASTRICHT4
VTT TECHNICAL RESEARCH CENTRE OF FINLAND4
ABBVIE INC3
ACADEMISCH ZIEKENHUIS LEIDEN3
BRISTOLMYERS SQUIBB COMPANY CORP3
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
EUROPEAN PATIENTS' FORUM3
FUNDACIO INSTITUT DE CIENCIES FOTONIQUES3
KAROLINSKA INSTITUTE3
KUNGLIGA TEKNISKA HOEGSKOLAN3
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN3
TAKEDA DEVELOPMENT CENTRE EUROPE3
THE UNIVERSITY OF BIRMINGHAM3
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIVERSITY OF SOUTHAMPTON3
UPPSALA UNIVERSITET3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
AMGEN LIMITED2
CARDIFF UNIVERSITY2
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP2
COVANCE LABORATORIES2
DANMARKS TEKNISKE UNIVERSITET2
DECHEMA GESELLSCHAFT FUER CHEMISCHE TECHNIK UND BIOTECHNOLOGIE E V2
DEGUSSA2
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EUROPEAN AIDS TREATMENT GROUP EV2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG EV2
FUNDACIO CENTRE DE REGULACIO GENOMICA2
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM2
FUNDACIO SANT JOAN DE DEU2
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD2
INSTITUT DE RECHERCHES SERVIER2
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV2
MEDIZINISCHE UNIVERSITAET WIEN2
MERCK SHARP & DOHME CORP2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
OWKIN FRANCE2
POLITECHNIKA WARSZAWSKA2
POLITECNICO DI MILANO2
PROCTER & GAMBLE EUROCOR N V2
PROTEOME SCIENCES PLC2
REGION HOVEDSTADEN2
RHEINISCHE FRIEDRICH WILHELMS UNIVERSITAET BONN2
RIJKSUNIVERSITEIT GRONINGEN2
ROBERT BOSCH2
SEMMELWEIS EGYETEM2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE2
STICHTING VU2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
TARTU ULIKOOL2
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY2
Constancy:

Total number of partners:947

Partner loyalty:
Frequent Partner: (> 2 projects): 270
Rare Partner: 677

Frequent / Rare Partner Ratio: 0.4

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS9
BIOLOGICAL SCIENCES9
SOCIAL AND ECONOMIC CONCERNS6
INDUSTRY AND TECHNOLOGY3
PROTECTING MAN AND HIS ENVIRON1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-11-01Collaboration for Prevention and Treatment of MDR Bacterial Infections COMBINEparticipant8.000.00011
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19269
2019-07-01Antibiotic Distribution and Recovery in Tissue AB-DiRecTparticipant3.429.2176
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-04-01Multiphoton Microscopy and Ultrafast Spectroscopy: Imaging meets Quantum MUSIQparticipant4.034.44716
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99151
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients NECESSITYparticipant8.200.00025
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00016
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00043
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-03-01Directed Protein Evolution for Synthetic Biology and Biocatalysis ES-Catparticipant3.827.03119
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01INternational Smart Collaborative Open-access hybrid Printed Electronics pilot line InSCOPEparticipant7.998.65211
2016-04-01Graphene-based disruptive technologies GrapheneCore1participant89.000.000186
2016-03-01FRAGments training NETwork FRAGNETparticipant3.842.48213
2016-03-01New Diagnostics for Infectious Diseases: “ND4ID” ND4IDparticipant3.860.50823
2016-02-01Targeted small-molecule Stabilisation of Protein-Protein Interactions TASPPIparticipant3.342.32312
2015-11-01Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 INNODIAparticipant17.630.00036
2015-01-01The next generation epigenetic medicine for inflammation EPIMACparticipant1.294.7852
2015-01-01Robust and affordable process control technologies for improving standards and optimising industrial operations ProPATparticipant5.484.16117
2012-01-01Novel Statistical Methodology for Diagnostic/Prognostic and Therapeutic Studies and Systematic Reviews MEDIASRESparticipant3.935.11410
2011-12-01Developing a global understanding of the PRC and NuRD complexes in stem cell differentiation, in health and disease 4DCELLFATEparticipant11.982.40313
2010-01-01Methods in Neuroimaging NeuroPhysicsparticipant2.912.9364
2009-12-01Synapses: from molecules to higher brain function and diseases SYMBADparticipant5.057.75013
2008-12-01Promotion of plasticity as a treatment for neurodegenerative conditions PLASTICISEparticipant5.199.44516
2008-09-01New molecular purification technology for pharmaceutical production NEMOPURparticipant2.937.8339
2008-06-01Computational prediction of drug cardiac toxicity PREDICTparticipant4.100.0009
2008-06-01IBD: proteases offer new targets for drug discovery IPODDparticipant2.999.25012
2007-01-01Systems biology strategies and metabolome engineering for the enhanced production of recombinant proteins in streptomyces STREPTOMICSparticipant2.850.85110
2006-04-01European graduate school of Neuroscience EURONparticipant2.347.49614
2005-11-07Interactions between adrenal steroids and beta amyloid in the regulation of neural stem cells ASBANSCcoordinator162.4481
2005-10-01Innovative medicines for europe INNOMEDparticipant11.998.52742
2005-02-01Integrated Multiscale Process Units with Locally Structured Elements IMPULSEparticipant10.500.00021
2004-07-30Data Grids for Process and Product Development using Numerical Simulation and Knowledge Discovery SIMDATparticipant11.000.00025
2004-01-01GENOME-BASED THERAPEUTIC DRUGS FOR DEPRESSION (GENDEP) GENDEPparticipant7.490.00019
2002-09-01Orexins / hypocretins - new targets for therapeutic control of feeding and sleeping disorders (OREXINS) OREXINSparticipant997.5455

Alias institution names:
  • GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum